GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dar Al Dawa Development and Investment (AMM:DADI) » Definitions » Net Margin %

Dar Al Dawa Development and Investment (AMM:DADI) Net Margin % : 3.49% (As of Mar. 2024)


View and export this data going back to 1978. Start your Free Trial

What is Dar Al Dawa Development and Investment Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Dar Al Dawa Development and Investment's Net Income for the three months ended in Mar. 2024 was JOD0.48 Mil. Dar Al Dawa Development and Investment's Revenue for the three months ended in Mar. 2024 was JOD13.63 Mil. Therefore, Dar Al Dawa Development and Investment's net margin for the quarter that ended in Mar. 2024 was 3.49%.

The historical rank and industry rank for Dar Al Dawa Development and Investment's Net Margin % or its related term are showing as below:

AMM:DADI' s Net Margin % Range Over the Past 10 Years
Min: -18.52   Med: 3.76   Max: 16.33
Current: 4.34


AMM:DADI's Net Margin % is ranked better than
53.09% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 3.06 vs AMM:DADI: 4.34

Dar Al Dawa Development and Investment Net Margin % Historical Data

The historical data trend for Dar Al Dawa Development and Investment's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dar Al Dawa Development and Investment Net Margin % Chart

Dar Al Dawa Development and Investment Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.39 16.33 2.03 3.29 4.22

Dar Al Dawa Development and Investment Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.64 4.04 4.62 4.91 3.49

Competitive Comparison of Dar Al Dawa Development and Investment's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Dar Al Dawa Development and Investment's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dar Al Dawa Development and Investment's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dar Al Dawa Development and Investment's Net Margin % distribution charts can be found below:

* The bar in red indicates where Dar Al Dawa Development and Investment's Net Margin % falls into.



Dar Al Dawa Development and Investment Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Dar Al Dawa Development and Investment's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=3.161/74.879
=4.22 %

Dar Al Dawa Development and Investment's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=0.475/13.626
=3.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dar Al Dawa Development and Investment  (AMM:DADI) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Dar Al Dawa Development and Investment Net Margin % Related Terms

Thank you for viewing the detailed overview of Dar Al Dawa Development and Investment's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dar Al Dawa Development and Investment (AMM:DADI) Business Description

Traded in Other Exchanges
N/A
Address
Naour, P.O. Box 9364, Amman, JOR, 11191
Dar Al Dawa Development and Investment is a pharmaceutical company. The main objectives of the company are to manufacture pharmaceutical, chemical, pharmaceutical, and related products and to import medicines. It offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, dermatology, eye-ear preparations, gastroenterology and metabolism, genitourinary system and sex hormones, musculoskeletal system, nervous system, ophthalmological/otological, and respiratory system, as well as vitamins. The company's geographical segments are Levant and Iraq, Gulf and Yemen, Africa, and Europe and Asia.

Dar Al Dawa Development and Investment (AMM:DADI) Headlines

No Headlines